Quantcast
Last updated on April 20, 2014 at 17:20 EDT

Latest Onyx Pharmaceuticals Stories

2014-04-02 08:33:07

SAN DIEGO, April 2, 2014 /PRNewswire/ -- Halozyme Therapeutics, Inc. (NASDAQ: HALO) today announced the appointment of Sunil Joshi as Vice President and Global Product Team Lead (GPTL), for PEGPH20 and Oncology. With over 20 years of experience in the biopharmaceutical industry, Mr. Joshi brings strong expertise in oncology drug development and commercialization. Mr. Joshi most recently served as Head of New Product Strategy and Commercial Assessment at Onyx Pharmaceuticals where he...

2014-03-31 23:37:07

Top Tier Panelists from Onyx Pharmaceuticals, BioMarin Pharmaceutical, San Francisco State University, and Clinovo Share Experience on How to Conduct Successful Outsourcing Strategies Sunnyvale, CA (PRWEB) March 31, 2014 Outsourcing experts from Onyx Pharmaceuticals, San Francisco State University (SFSU), BioMarin Pharmaceutical, and Clinovo discussed the topic 'Manage In-house and Outsourced Clinical Trials: Vendor Selection, Project Coordination, and Resource Management' at the...

2014-03-24 08:28:34

SAN DIEGO, March 24, 2014 /PRNewswire/ -- Seragon Pharmaceuticals Inc., a clinical-stage biotechnology company focused on the development of drugs for hormone-driven cancers, today announced the appointment of N. Anthony Coles (Tony), M.D. to the company's Board of Directors. Dr. Coles brings nearly 30 years of experience in the healthcare, biotechnology and pharmaceutical industries. Most recently, Dr. Coles served as President, Chief Executive Officer and Chairman of the Board of...

2014-03-20 08:29:33

SAN DIEGO, March 20, 2014 /PRNewswire/ -- Mirati Therapeutics, Inc. (NASDAQ: MRTX) today announced that biotechnology industry veteran William Ringo has joined its board of directors. "Bill has excellent experience in developing and driving strategies that have enabled success for both large pharmaceutical companies and start-up biotechs. Bill's experience and guidance will be extremely helpful as we enter a transformational year in the development of each of our programs and chart...

2014-03-11 04:21:19

WHIPPANY, N.J., THOUSAND OAKS, Calif. and SOUTH SAN FRANCISCO, Calif., March 11, 2014 /PRNewswire/ -- Bayer HealthCare Pharmaceuticals Inc. and Onyx Pharmaceuticals, Inc., an Amgen subsidiary (Nasdaq: AMGN), today announced that a Phase 3 trial evaluating the investigational use of NEXAVAR(®) (sorafenib) tablets as an adjuvant treatment for patients with hepatocellular carcinoma (HCC), or liver cancer, who had no detectable disease after surgical resection or local ablation, did not...

2014-03-06 08:31:36

SEATTLE and SOUTH SAN FRANCISCO, Calif., March 6, 2014 /PRNewswire/ -- Immune Design, a clinical-stage immunotherapy company focused on the development of novel immune-based therapies for cancer and other chronic conditions, today announced the appointment of biotechnology and pharmaceutical industry veteran William ("Bill") R. Ringo to the company's board of directors. http://photos.prnewswire.com/prnvar/20130926/SF87058LOGO Mr. Ringo brings more than four decades of...

2014-02-05 16:27:50

KANSAS CITY, Kan., Feb. 5, 2014 /PRNewswire/ -- Aratana Therapeutics, Inc. (NASDAQ: PETX), a pet therapeutics company focused on the licensing or acquisition, development and commercialization of innovative biopharmaceutical products for cats, dogs and other companion animals, today announced additions to its Board of Directors. The Board has appointed two new members; Laura Brege, President and Chief Executive Officer of Nodality, Inc., a privately held life sciences company, and...

2014-01-15 20:21:44

MENLO PARK, Calif., Jan. 15, 2014 /PRNewswire/ -- SRI International, a prestigious research and innovation center, has named Mariann Byerwalter as Chairman of SRI International's Board of Directors, effective January 1, 2014. Admiral Vern Clark, who had been chairman since 2010, will remain on the Board. Byerwalter was most recently Chairman of the Board of Directors of the Stanford Hospital and Clinics and is a former Trustee of Stanford University. Prior to that, she served as...

2013-12-17 16:23:46

Helen Torley to assume role of President and CEO; Gregory I. Frost to lead Intrexon's Health Sector and will remain on Halozyme's Scientific Advisory Board SAN DIEGO, Dec. 17, 2013 /PRNewswire/ -- Halozyme Therapeutics, Inc. (NASDAQ: HALO) announced today that Helen Torley, M.B. Ch. B., M.R.C.P., will be joining Halozyme as President and Chief Executive Officer on January 6, 2014. She will also become a member of Halozyme's Board of Directors. Dr. Torley was most recently Executive...

2013-12-13 08:24:36

SANTA BARBARA, Calif., Dec. 13, 2013 /PRNewswire/ -- VG Life Sciences, (OTC Pink: VGLS) a biotechnology company, announces today an update to its Physician-IND Phase I Study to test tolerability and toxicity of its patented technology in patients with advanced stage solid tumors. This study is being conducted at the Cancer Therapy and Research Center at the University of Texas Health Sciences Center at San Antonio . The primary investigator is medical oncologist Tyler Curiel, M.D.,...